Amyris teams with Genome Compiler for open source testing program

In California, Amyris, Inc. and Genome Compiler Corp. announced the availability of an open testing program for pharma and biotech companies to explore DNA design and construction solutions. The two companies announced a collaboration agreement in March 2015 to integrate Amyris’s automated lab services with Genome Compiler’s online design tools and e-commerce platform to enable users to design and order DNA or other biological products seamlessly. Today, the companies are extending an open invitation to interested parties to visit Genome Compiler’s website page where they can source helpful information and express their interest in the program.

Through the integrated platform, researchers can leverage a comprehensive solution from design to delivery that represents a first-of-its-kind integrated DNA design and construction service. The service allows for greater levels of automation, enabling faster progress, and will be less expensive and more sophisticated than other available offerings. Prospective customers will have access to Genome Compiler’s advanced software tools, along with Amyris’s extensive libraries of verified genetic parts, DNA construction and editing methods, all derived from its expertise in innovative bioscience technology.